Search Results 1391-1400 of 11214 for Antifungal Resistance

  1. A Study To Evaluate Abatacept To Treat Giant Cell Arteritis - Mayo Clinic

    Patients with a history of systemic fungal infections (such as histoplasmosis, blastomycosis, or coccidiomycosis). Patients with a history of primary ...

  2. SER-262 Versus Placebo In Adults With Primary Clostridium Difficile Infection To Prevent Recurrence - Mayo Clinic

    The study will involve administering a single dose of investigational drug or placebo in ascending dose cohorts. This study is designed to evaluate the safety ...

  3. Efficacy And Safety Of Benralizumab In EGPA Compared To Mepolizumab - Mayo Clinic

    The purpose of this study is to evaluate the effectiveness and safety of Benralizumab compared to Mepolizumab to treat Eosinophilic Granulomatosis with ...

  4. Study To Determine Risk Factors For Post-operative Infection In Inflammatory Bowel Disease - Mayo Clinic

    Understanding of how best to treat inflammatory bowel disease (IBD) has evolved over the last ten years. Evidence now suggests that the most effective ...

  5. Rheumatoid arthritis - Doctors and departments - Mayo Clinic

    This ongoing condition can affect more than just the joints. It also can damage skin, eyes, lungs, heart and blood vessels.

  6. A Phase 2 Study Of Anti-PD-L1 Antibody Atezolizumab In Alveolar Soft Part Sarcoma - Mayo Clinic

    Background: Sometimes the cancer advanced alveolar soft part sarcoma (ASPS) cannot be helped with surgery or other treatment. The drug atezolizumab unblocks the ...

  7. Clinical trials - Oncology (Medical)

    Investigation Of Ubamatamab Combination Therapy In Adult Participants With Platinum-Resistant Ovarian Cancer. Jacksonville, Fla. This study is researching an ...

  8. Arthritis - Doctors and departments - Mayo Clinic

    Learn about how different types of arthritis affect joints in different ways, along with how to get relief from arthritis pain.

  9. Antiphospholipid syndrome - Doctors and departments - Mayo Clinic

    Learn about causes and treatment of this blood disorder that mainly affects women and may cause blood clots and miscarriages.

  10. Erlotinib Hydrochloride And Cabozantinib-s-Malate Alone Or In Combination As Second Or Third Line Therapy In Treating Patients With Stage IV Non-Small Cell Lung Cancer - Mayo Clinic

    Erlotinib Hydrochloride And Cabozantinib-s-Malate Alone Or In Combination As Second Or Third Line Therapy In Treating Patients With Stage IV Non-Small Cell Lung ...